When you join Ciders for ALS, you will receive a special blend of experimental hop varietals
each year, free of charge, to make your own unique cider. In return, we just ask that you donate
a minimum of $1 for every glass sold of your specialty cider, to advance ALS research at the ALS
Therapy Development Institute (ALS TDI).
WHAT IS CIDERS FOR ALS?
Ciders for ALS is a national fundraising campaign to raise funds and awareness for ALS, or
Lou Gehrig's disease. The program is modeled after our Ales for ALS™ program but instead of
brewing beer from the annual hop blend, cideries produce cider. Loftus Ranches and Yakima Chief
Hops donate a unique hop blend, developed by master brewers, to select cideries across the
country. Cider makers create a special cider from the hops and donate a portion of their
cider's sales to ALS TDI.
WHY JOIN CIDERS FOR ALS?
- Associate your cidery with a great cause.
- Gain local and national exposure via promotion and press releases.
- Feature on our social media channels.
- Become a part of ALS research to #EndALS.
HOW IT WORKS
Create a cider that will make a difference. This is the program in few simple steps:
THE 2020 HOP BLEND
Each year, Loftus Ranches and Yakima Chief Hops donate a unique hop blend developed by
master brewers to select cideries across the country. Once cider makers accept our Ciders for ALS
invitation, they select their desired quantity of hops and schedule their delivery date.
HOW DOES CIDER FUND ALS RESEARCH?
Ciders for ALS participants donate $1 to ALS TDI for each glass sold of their specialty
Ciders. Donations directly fund cutting-edge research at ALS TDI, the world's foremost
drug discovery lab focused solely on ALS.
Programs like Ciders for ALS provide vital support for ALS TDI and their mission to
discover and develop effective treatments and cures for every person with ALS.
If you are a traditional cidery, we understand that the donation per glass could be less due
to the aging process and overhead cost.
WHAT IS ALS?
Every 90 minutes, someone is diagnosed with ALS, also known as Lou Gehrig's disease or
Motor Neuron Disease (MND). It is a progressive, neurodegenerative disease that causes muscle
weakness, difficulty breathing and swallowing, and paralysis while leaving the senses intact. Most
survive three to five years after diagnosis. An estimated 500,000 people worldwide live with the
disease. There is no effective treatment nor cure.
ABOUT THE ALS THERAPY DEVELOPMENT INSTITUTE
The ALS Therapy Development Institute and our scientists actively discover and develop
treatments for ALS. We are the world's first and largest nonprofit biotech focused 100 percent on
ALS research. Led by people with ALS and drug development experts, we understand the urgent
need to slow and stop this disease. Learn more at www.als.net